Analytical Overview: Lexeo Therapeutics Inc (LXEO)’s Ratios Tell a Financial Story

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

As of close of business last night, Lexeo Therapeutics Inc’s stock clocked out at $3.27, up 5.48% from its previous closing price of $3.10. In other words, the price has increased by $5.48 from its previous closing price. On the day, 0.71 million shares were traded.

Ratios:

To gain a deeper understanding of LXEO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.42 and its Current Ratio is at 3.42. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $28.

On June 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $22. On November 28, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on November 28, 2023, with a $20 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when Townsend Richard Nolan sold 1,074 shares for $2.77 per share. The transaction valued at 2,979 led to the insider holds 221,173 shares of the business.

Adler Eric sold 585 shares of LXEO for $1,623 on May 16 ’25. The Chief Medical Officer now owns 67,681 shares after completing the transaction at $2.77 per share. On May 16 ’25, another insider, Robertson Jenny, who serves as the Chief Legal Officer of the company, sold 521 shares for $2.77 each. As a result, the insider received 1,445 and left with 63,098 shares of the company.

Stock Price History:

Over the past 52 weeks, LXEO has reached a high of $19.50, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 6.54%, while the 200-Day Moving Average is calculated to be -46.64%.

Shares Statistics:

A total of 33.19M shares are outstanding, with a floating share count of 25.01M. Insiders hold about 24.67% of the company’s shares, while institutions hold 82.00% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.